Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2025
About
Suggestions
Contact Us
zanolimumab
MeSH Supplementary Concept Data 2026
Details
Concepts
MeSH Supplementary
zanolimumab
Unique ID
C520522
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C520522
Entry Term(s)
MDX-016
humax-CD4
Pharm Action
Antineoplastic Agents, Immunological
Registry Numbers
HG3L8885M0
Heading Mapped to
*Antibodies, Monoclonal, Humanized
Frequency
16
Note
a human monoclonal antibody targeted against CD4 for the potential treatment of cutaneous and noncutaneous T-cell lymphomas
Source
Curr Opin Mol Ther 2007 Apr;9(2):197-203
Date Introduced
2007/06/20
Last Updated
2019/11/01
Expand All
Collapse All
zanolimumab
Preferred
Concept UI
M0510732
Registry Numbers
HG3L8885M0
Terms
zanolimumab
Preferred Term
Term UI
T700305
Date
06/20/2007
LexicalTag
NON
ThesaurusID
MDX-016
Narrower
Concept UI
M000654731
Terms
MDX-016
Preferred Term
Term UI
T000966316
Date
08/22/2019
LexicalTag
LAB
ThesaurusID
NLM (2020)
humax-CD4
Narrower
Concept UI
M000654732
Terms
humax-CD4
Preferred Term
Term UI
T000966317
Date
08/22/2019
LexicalTag
TRD
ThesaurusID
NLM (2020)
page delivered in 0.004s